WT1 contributes to leukemogenesis: Expression patterns in 7,12-dimethylbenz[a]anthracene (DMBA)-induced leukemia
Open Access
- 7 August 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 72 (4) , 696-699
- https://doi.org/10.1002/(sici)1097-0215(19970807)72:4<696::aid-ijc23>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemiaInternational Journal of Cancer, 1997
- Mutation analysis of the WT1 gene in sporadic childhood leukaemiaLeukemia, 1997
- N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in long-evans ratsCancer Letters, 1995
- WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemiaBlood, 1994
- Expression of GATA‐binding transcription factors in rat hepatocytesFEBS Letters, 1994
- GATA-binding transcription factors in hematopoietic cellsBlood, 1992
- Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumpingNature, 1990
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locusCell, 1990
- Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic familyNucleic Acids Research, 1985
- Induction of leukemia in rat by pulse doses of 7,12-dimethylbenz(a)anthracene.Proceedings of the National Academy of Sciences, 1966